Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
276.5 GBX | +6.35% | +28.60% | +25.68% |
Apr. 29 | FTSE 100 as investors look to Fed rate decision | AN |
Apr. 29 | Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024 |
Evolution of the average Target Price on Oxford Biomedica plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Oxford Biomedica plc
Stifel Nicolaus | |
Liberum Capital | |
Numis | |
JPMorgan | |
RBC Capital Markets |
EPS Revisions
- Stock Market
- Equities
- OXB Stock
- Consensus Oxford Biomedica plc